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Background: Intensive statin therapy in patients with acute myocardial infarction was strongly recommended. However,some clinical and 
epidermiologic data have raised some concerns about very low lipid level such as increasing mortality or intracranial bleeding. The aim of this study 
was to identify whether statin therapy in low LDL level could affect long-term clinical outcome or not.
Methods: A total of 407 AMI patients (65.3± 13.2 years, 72.5% males) enrolled in a nationwide prospective Korea Acute Myocardial Infarction 
Registry (KAMIR) between Nov. 2005 and Jan. 2008 who had LDL level below 70 mg/dL were included in the present study. The patients were 
divided into two groups whether prescribed statin at the time of discharge or not: group I (prescribed, n=251), and group II (Not prescribed, n=156).
Results: During the one-year follow-up, all cause of death or myocardial infarction (MI) occurred in 50 patients (12.3%). There were no significant 
differences in age, admission glucose, creatinine level, and ejection fraction (EF) on periprocedural echocardiogram. There were significant 
differences between two groups in the incidence of treated hyperlipidemia (14.5% vs. 7.1%, p=0.024), hypertension (57.6% vs. 45.8%), and more 
diabetes (35.2% vs. 28.8%, p=0.185) without statistically differences. The incidence of high-sensitivity C-reactive protein level (hsCRP) above 2mg/
dL (47.1% vs. 46.3%, p=0.888) was similar. By using multi-variate Cox regression analysis, which was adjusted with the parameters of post-discharge 
GRACE (The Global Registry of Acute Coronary Events) score and mentioned above, there were no significant differences in death or MI rates between 
two groups [hazard ratio (HR) = 1.70, 95% CI (confidential interval) 0.72-4.06, p=0.229], even in case of patients with hsCRP above 2 mg/dL, no 
significant differences also existed (HR 1.51, 95% CI 0.42-5.41, p=0.527).
Conclusions: Hospital discharge long-term statin therapy did not reduce death/MI at one year in patients with LDL level below 70 mg/dL, even 
combined with high hsCRP levels.
